Related Experiment Video
Updated: Jul 6, 2026

Oligopeptide Competition Assay for Phosphorylation Site Determination
Published on: May 18, 2017
Protein kinase D links Gq-coupled receptors to cAMP response element-binding protein (CREB)-Ser133 phosphorylation in
Nazira Ozgen1, Maria Obreztchikova, Jianfen Guo
1Department of Pharmacology, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.
Abstract:
Many growth regulatory stimuli promote cAMP response element-binding protein (CREB) Ser(133) phosphorylation, but the physiologically relevant CREB-Ser(133) kinase(s) in the heart remains uncertain. This study identifies a novel role for protein kinase D (PKD) as an in vivo cardiac CREB-Ser(133) kinase. We show that thrombin activates a PKCdelta-PKD pathway leading to CREB-Ser(133) phosphorylation in cardiomyocytes and cardiac fibroblasts. alpha(1)-Adrenergic receptors also activate a PKCdelta-PKD-CREB-Ser(133) phosphorylation pathway in cardiomyocytes. Of note, while the epidermal growth factor (EGF) promotes CREB-Ser(133) phosphorylation via an ERK-RSK pathway in cardiac fibroblasts, the thrombin-dependent EGFR transactivation pathway leading to ERK-RSK activation does not lead to CREB-Ser(133) phosphorylation in this cell type. Adenoviral-mediated overexpression of PKCdelta (but not PKCepsilon or PKCalpha) activates PKD; PKCdelta and PKD1-S744E/S748E overexpression both promote CREB-Ser(133) phosphorylation. Pasteuralla multocida toxin (PMT), a direct Galpha(q) agonist that induces robust cardiomyocyte hypertrophy, also activates the PKD-CREB-Ser(133) phosphorylation pathway, leading to the accumulation of active PKD and Ser(133)-phosphorylated CREB in the nucleus, activation of a CRE-responsive promoter, and increased Bcl-2 (CREB target gene) expression in cardiomyocyte cultures. Cardiac-specific Galpha(q) overexpression also leads to an increase in PKD-Ser(744)/Ser(748) and CREB-Ser(133) phosphorylation as well as increased Bcl-2 protein expression in the hearts of transgenic mice. Collectively, these studies identify a novel Galpha(q)-PKCdelta-PKD-CREB-Ser(133) phosphorylation pathway that is predicted to contribute to cardiac remodeling and could be targeted for therapeutic advantage in the setting of heart failure phenotypes.
Insights
Protein Kinase D (PKD) is identified as a key cardiac kinase that phosphorylates CREB-Ser(133). This novel Gαq-PKCδ-PKD-CREB pathway contributes to cardiac remodeling and may offer therapeutic targets for heart failure.
Area of Science:
- Cardiovascular Biology
- Molecular Signaling
- Cellular Physiology
Background:
- cAMP response element-binding protein (CREB) phosphorylation at Ser(133) is crucial for growth regulation.
- The specific kinases responsible for cardiac CREB-Ser(133) phosphorylation in vivo remain unclear.
Purpose of the Study:
- To identify the physiologically relevant kinase(s) for CREB-Ser(133) phosphorylation in the heart.
- To elucidate novel signaling pathways involved in cardiac growth regulation and remodeling.
Main Methods:
- Utilized cardiomyocytes and cardiac fibroblasts.
- Employed adenoviral-mediated gene overexpression (PKCδ, PKD1-S744E/S748E).
- Investigated signaling pathways activated by thrombin, α(1)-adrenergic receptors, epidermal growth factor (EGF), and Pasteurella multocida toxin (PMT).
- Examined cardiac-specific Gαq overexpression in transgenic mice.
Main Results:
- Identified Protein Kinase D (PKD) as a novel cardiac CREB-Ser(133) kinase.
- Demonstrated that thrombin and α(1)-adrenergic receptors activate a PKCδ-PKD pathway leading to CREB-Ser(133) phosphorylation.
- Showed that PMT and cardiac-specific Gαq overexpression activate the PKD-CREB-Ser(133) pathway, increasing nuclear PKD and phosphorylated CREB, CRE-reporter activity, and Bcl-2 expression.
- Observed distinct signaling for EGF-induced CREB phosphorylation in cardiac fibroblasts.
Conclusions:
- A novel Gαq-PKCδ-PKD-CREB-Ser(133) phosphorylation pathway is identified in the heart.
- This pathway is implicated in cardiomyocyte hypertrophy and cardiac remodeling.
- Targeting this pathway may offer therapeutic benefits for heart failure phenotypes.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
MAPK Signaling Cascades
Amplifying Signals via Enzymatic Cascade
IP3/DAG Signaling Pathway
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
GPCRs Regulate Adenylyl Cylase Activity
Two...

